by Ellie Lampton | Sep 4, 2024
Truveta will enable The CHOICE Institute with complete, timely, and clean real-world data to improve patient care and advance medicine The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy has...
by Ellie Lampton | Jul 8, 2024
In the largest comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data – now published in JAMA Internal Medicine – Truveta Research found that patients with overweight or obesity taking tirzepatide were...
by Ellie Lampton | Jun 17, 2024
With industry-leading certifications and rigorous third-party audits, Truveta announces new capabilities to enable successful regulatory submissions and audits. BELLEVUE, Wash. – June 18, 2024 – Today, Truveta announced regulatory and audit capabilities to support its...
by Ellie Lampton | May 13, 2024
BELLEVUE, Wash. – May 13, 2024 – Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and CEO of Providence, as its new Board of Directors Chair. Truveta’s Board of Directors...
by Ellie Lampton | May 2, 2024
From detailed family history and complex concepts from a wide range of therapeutic areas to millions of de-identified medical images, Truveta empowers researchers with the most complete, timely, and clean data. BELLEVUE, Wash. – May 2, 2024 – Today Truveta announced...